• Oculus Announces FDA 501K Clearance of Microcyn Technology
    PETALUMA, Calif. -- Hoji Alimi, founder and president of Oculus Innovative Sciences, today announced that the company has received its first 510K clearance  from the Food and Drug Administration (FDA) to market Dermacyn™ Wound Care, formulated with Microcyn™ ...More
    May 9, 2005 Posted in News
  • Study Reports HAIs are on the Rise
    WASHINGTON, D.C. -- Infection control practitioners (ICPs) devote their careers to preventing healthcare-associated infections (HAI) by educating healthcare personnel on infection prevention measures, conducting infection surveillance, and reporting infection data to ...More
    May 9, 2005 Posted in News
  • Inhibitex Reports Favorable Results From Aurexis Phase II Trial for the Treatment of Staph Bloodstream Infections
    ATLANTA -- Inhibitex, Inc.  today reported top-line findings from its Phase II clinical trial of Aurexis for the adjunctive treatment of serious, life threatening Staphylococcus aureus (S. aureus) bloodstream infections in combination with antibiotics. Favorable ...More
    May 9, 2005 Posted in News
  • Two Studies Document Rise of Superbugs in the Environment
    As science gets wiser, so do the bugs. The rates of drug-resistant bacteria infecting patients in the community and in the hospital have been increasing steadily in recent years, according to two new studies in the June, 2005 15 issue of Clinical Infectious Diseases. Drug ...More
    May 9, 2005 Posted in News
  • First Combination Vaccine Approved to Help Protect Adolescents Against Whooping Cough
    The Food and Drug Administration (FDA) today approved the first combination vaccine that provides a booster immunization against pertussis (whooping cough) in combination with tetanus and diphtheria for adolescents. The vaccine will be marketed as Boostrix by ...More
    May 3, 2005 Posted in News
  • Nurses Fight Back Against MRSA
    Great Britain -- A new treatment protocol to reduce MRSA infections using an antimicrobial wound dressing ACTISORB* Silver 220 at open treatments sites is so successful that it has been made standard policy across the Doncaster and Bassetlaw NHS Hospitals Trust.(1) The ...More
    May 3, 2005 Posted in News
  • Proper Handwashing is Essential for Infection Prevention
    WASHINGTON, D.C. -- Do not let a stomach virus damper your summer fun and spoil your vacation. Families can protect themselves by engaging in proper hand hygiene to prevent the spread of infections. A recent article in the Journal of the American Medical Association (JAMA) ...More
    May 3, 2005 Posted in News, Environmental Hygiene, Hand Hygiene
  • Antibiotic Might Fight HIV-Induced Neurological Problems
    By studying animals, Johns Hopkins researchers have discovered that the antibiotic minocycline might help alleviate HIV's negative effects on the brain and central nervous system, problems that can develop even though antiretroviral therapy controls the virus elsewhere in ...More
    May 2, 2005 Posted in News
  • New Data Shows Use of Antibiotics to Treat Ear Infections is Falling
    The proportion of children who were given an antibiotic specifically to treat otitis media, a commonly diagnosed ear condition, declined from 14.4 percent in 1996 to 11.5 percent in 2001, according to new data from HHS’ Agency for Healthcare Research and Quality (AHRQ). The ...More
    May 2, 2005 Posted in News
  • Burden of Parasitic Worm Infection is Greater Than Previous Estimates
    The disability associated with schistosomiasis is far greater than previously thought, concludes a study published in this week’s issue of The Lancet. Chronic schistosomiasis is an infection caused by a parasitic worm. More than 200 million people are affected worldwide, ...More
    May 2, 2005 Posted in News